IBD-FITT研究——中等强度运动用于中度活动期炎症性肠病患者:一项开放标签随机对照试验
该研究为开放标签随机对照试验,计划纳入150例中度活动期炎症性肠病(IBD)患者,等比例分配至12周有氧运动干预组与常规照护组,采用优效性设计。干预包括每周两次60分钟监督下运动及一次家庭训练,运动强度为最大心率的60%–80%,并辅以在线生活方式指导视频。主要结局涵盖疾病特异性健康相关生活质量(IBDQ)、一般健康状况及生物标志物等探索性指标。
要点
- 12周中等强度有氧运动干预用于中度活动期IBD患者,采用优效性设计开放标签随机对照试验。
- 干预组每周两次60分钟监督下运动加一次家庭训练,强度为最大心率的60%–80%。
- 结局包括IBDQ、腰围、疾病活动度评分、血压、血脂、EQ5D及CRP、粪钙卫蛋白等生物标志物。
核心结论
- 该试验将补充运动对克罗恩病和溃疡性结肠炎患者可能效果的证据,或可阐明运动能否作为辅助治疗附加手段而获益。
- 该试验可能提供一种新的患者主动参与的疾病管理方法。
研究设计与样本
- 开放标签随机对照试验,采用优效性设计,计划纳入150例中度活动期IBD成年患者,等比例分配至干预组与常规照护组。
- 干预为12周有氧运动项目,包括每周两次60分钟监督下运动及一次每周家庭训练,中等运动强度定义为最大心率的60%–80%。
- 干预组另提供15–25分钟在线生活方式指导视频课程,对照组也提供相同在线视频课程。
- 生活质量问卷在入组时和研究结束时以电子方式发送,血样和粪钙卫蛋白样本在基线、第4周、第8周及12周(研究结束)采集。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis are chronic autoimmune lifelong diseases with fluctuating activity over time. The treatment includes medical therapy and surgery, however, there is no definite cure. Therefore, the quest for new and supplementary treatment options is imperative to improve patients' general health and quality of life. Physical activity and exercise have been suggested to be elements in both the prevention and supplementary treatment of IBD; however, this is based on limited underpowered trials. Thus, the role of exercise as a treatment option still has to be settled. We aim to investigate the effect of a 12-week exercise intervention in adult patients with moderately active IBD on three categories of outcomes (1) disease-specific health-related quality of life (IBDQ); (2) general health status of the patients, i.e., waist circumference, disease activity by clinical scorings systems (Harvey Bradshaw Index, Simple Clinical Colitis Activity Index), blood pressure, blood lipids, and non-disease specific quality of life (EQ5D) scores; and (3) explorative outcomes on biomarkers (C-reactive protein and fecal calprotectin) plus different biomarkers of immunology (cytokine panel). METHODS: We will apply a superiority design in this open-label randomized clinical trial including 150 patients equally allocated to intervention and usual care. The intervention will be based on a 12-week aerobic exercise program and will include two supervised exercise sessions of 60 min per week, combined with one weekly home training session. We have defined a moderate exercise level as 60-80% of patients' maximum heart rate. The patients in the intervention group will also be offered an online video lesson of 15-25 min on lifestyle guidance, and the same online video lesson will be offered in the comparator group. Questionnaires on quality of life will be forwarded electronically both at inclusion and at the end of the study, and the patients will have blood samples, and fecal samples for calprotectin at baseline, weeks 4 and 8, as well as after 12 weeks (study end). DISCUSSION: This will be a clinical trial investigating the effect of exercise on patients with Crohn's disease and ulcerative colitis. This trial will add to the evidence on the possible effect of exercise and might clarify whether exercise can benefit as a supplementary treatment addendum. Thus, the trial may provide a new patient-active disease management approach. TRIAL REGISTRATION: ClinicalTrials.gov NCT04816812. Date of first registration: March 23, 2021.
引用
- Lund K, Knudsen T, Kjeldsen J, et al. The IBD-FITT study - moderate-intensity exercise for patients with inflammatory bowel disease with moderate disease activity: an open-label randomized controlled trial. Trials. 2023. PMID: 37986021. doi:10.1186/s13063-023-07781-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。